WIN-Partners Past Earnings Performance
Past criteria checks 1/6
WIN-Partners's earnings have been declining at an average annual rate of -6.6%, while the Healthcare industry saw earnings growing at 6% annually. Revenues have been growing at an average rate of 1.5% per year. WIN-Partners's return on equity is 7.5%, and it has net margins of 2.3%.
Key information
-6.6%
Earnings growth rate
-6.4%
EPS growth rate
Healthcare Industry Growth | 7.9% |
Revenue growth rate | 1.5% |
Return on equity | 7.5% |
Net Margin | 2.3% |
Next Earnings Update | 14 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How WIN-Partners makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 74,396 | 1,694 | 6,811 | 0 |
30 Sep 23 | 72,417 | 2,008 | 6,648 | 0 |
30 Jun 23 | 71,493 | 1,937 | 6,481 | 0 |
31 Mar 23 | 70,854 | 2,047 | 6,192 | 0 |
31 Dec 22 | 68,888 | 1,920 | 6,133 | 0 |
30 Sep 22 | 68,863 | 1,773 | 5,961 | 0 |
30 Jun 22 | 67,699 | 1,866 | 5,813 | 0 |
31 Mar 22 | 66,391 | 1,831 | 5,757 | 0 |
31 Dec 21 | 66,508 | 2,007 | 5,610 | 0 |
30 Sep 21 | 65,384 | 1,767 | 5,591 | 0 |
30 Jun 21 | 64,716 | 1,706 | 5,572 | 0 |
31 Mar 21 | 62,123 | 1,540 | 5,488 | 0 |
31 Dec 20 | 60,416 | 1,418 | 5,360 | 0 |
30 Sep 20 | 59,276 | 1,397 | 5,384 | 0 |
30 Jun 20 | 60,304 | 1,552 | 5,389 | 0 |
31 Mar 20 | 64,537 | 1,872 | 5,522 | 0 |
31 Dec 19 | 67,726 | 2,239 | 5,437 | 0 |
30 Sep 19 | 71,056 | 2,791 | 5,406 | 0 |
30 Jun 19 | 70,976 | 2,774 | 5,393 | 0 |
31 Mar 19 | 69,775 | 2,640 | 5,351 | 0 |
31 Dec 18 | 66,845 | 2,584 | 5,283 | 0 |
30 Sep 18 | 64,942 | 2,883 | 5,255 | 0 |
30 Jun 18 | 64,136 | 2,855 | 5,105 | 0 |
31 Mar 18 | 62,832 | 3,005 | 4,900 | 0 |
31 Dec 17 | 62,174 | 2,887 | 4,862 | 0 |
30 Sep 17 | 59,800 | 2,177 | 4,648 | 0 |
30 Jun 17 | 58,641 | 2,200 | 4,547 | 0 |
31 Mar 17 | 57,760 | 2,141 | 4,493 | 0 |
31 Dec 16 | 56,627 | 2,148 | 4,357 | 0 |
30 Sep 16 | 55,989 | 2,156 | 4,312 | 0 |
30 Jun 16 | 55,255 | 2,121 | 4,289 | 0 |
31 Mar 16 | 54,147 | 2,111 | 4,299 | 0 |
31 Dec 15 | 53,641 | 2,008 | 4,254 | 0 |
30 Sep 15 | 52,839 | 1,921 | 4,226 | 0 |
30 Jun 15 | 51,510 | 1,870 | 4,182 | 0 |
31 Mar 15 | 50,558 | 1,690 | 4,096 | 0 |
31 Dec 14 | 51,021 | 1,568 | 4,078 | 0 |
30 Sep 14 | 51,186 | 1,525 | 4,006 | 0 |
30 Jun 14 | 50,633 | 1,440 | 3,972 | 0 |
31 Mar 14 | 49,826 | 1,840 | 3,915 | 0 |
Quality Earnings: 3183 has high quality earnings.
Growing Profit Margin: 3183's current net profit margins (2.3%) are lower than last year (2.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 3183's earnings have declined by 6.6% per year over the past 5 years.
Accelerating Growth: 3183's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 3183 had negative earnings growth (-11.8%) over the past year, making it difficult to compare to the Healthcare industry average (6.7%).
Return on Equity
High ROE: 3183's Return on Equity (7.5%) is considered low.